Related Experiment Video
Updated: May 11, 2025

11:13
Creating Sub-50 Nm Nanofluidic Junctions in PDMS Microfluidic Chip via Self-Assembly Process of Colloidal Particles
Published on: March 13, 2016
10.6K
Controlled Nanoconfinement in a Microfluidic Modular Bead Array Device via Elastomeric Diaphragm Collapse for
Abdullah-Bin Siddique1, Jui-Hong Weng2, Deng-Kai Yang2
1Electrical & Computer Engineering, University of Virginia, Charlottesville, VA, 22904-4743, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|April 17, 2025
Summary
This study presents a novel nanoconfinement device that significantly accelerates biomolecular binding kinetics. This technology enhances receptor screening and selection based on binding affinities, improving drug discovery and diagnostics.
Area of Science:
- Biotechnology
- Nanotechnology
- Biophysics
Background:
- Diffusional transport limitations hinder biomolecular binding kinetics.
- Nanoscale confinement strategies can overcome these limitations.
- Efficient receptor screening requires enhanced binding affinity measurements.
Purpose of the Study:
- To develop a modular and multiplexed device for creating nanoconfinement.
- To enhance receptor binding kinetics for improved screening and selection.
- To validate the device's performance in accelerating biomolecular interactions.
Main Methods:
- Utilized an elastomeric diaphragm collapsing onto microbead arrays for nanoconfinement.
- Integrated a strain sensor for controlled vertical displacement and nanoposts for lateral extent control.
- Employed repeated diaphragm withdrawal to promote bulk transport and enhance binding.
- Enabled multiplexed screening in microwells and downstream quantification via quantitative PCR (q-PCR).
Main Results:
- Demonstrated significantly enhanced biomolecular binding under nanoconfinement (1 Hz pressurization).
- Achieved rapid DNA immobilization with a time constant of ~6 minutes compared to >60 minutes without confinement.
- Showcased saturating binding of target molecules with optimal aptamers, reaching 88% site occupancy versus 5% without confinement.
- Validated the screening of candidate receptors based on binding affinity parameters.
Conclusions:
- The developed nanoconfinement device effectively accelerates biomolecular binding kinetics.
- This platform facilitates efficient multiplexed screening and selection of receptors based on binding affinities.
- The technology holds promise for applications in diagnostics and drug discovery.

